2011年 · 第44卷第12期

Endovascular intervention technology originated from peripheral blood vessels and developed from coronary arteries. It has been introduced in the prevention and treatment of cerebrovascular diseases in recent 20 years. Although this technology has been used for a short time in cerebrovascular diseases, it has developed very rapidly. The practitioners of vascular intervention in cerebrovascular disease come from different specialties, and the technical routes and treatment strategies adopted vary widely. These characteristics make it crucial to develop uniform guidelines to guide standardized clinical practice. Based on this consideration, American Heart Association (AHA), European Stroke Organization (ESO), American Academy of Neurology (AAN), American Society of Interventional Radiology (SIR) and other professional societies have launched guidelines for interventional treatment of cerebrovascular diseases. Based on the results of previous clinical studies, these guidelines adopt evidence-based medicine methods, and systematically standardize the clinical application of endovascular interventional technology in cerebrovascular diseases from many aspects such as treatment methods, patient screening, intraoperative and postoperative medication, and complication prevention and treatment. In the Chinese Guidelines for Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2010, interventional therapy is also involved, but it is not detailed. Generally speaking, endovascular interventional therapy for cerebrovascular diseases in China is still in the development stage, and there is no special guideline in China. This guideline mainly recommends the interventional diagnosis and treatment of ischemic cerebrovascular disease, and the purpose is to provide a reference for clinicians when selecting patients for interventional treatment, conducting standardized evaluation and formulating interventional treatment strategies. During the development of the guidelines, the contents of internationally important guidelines were referred to, while the latest evidence-based medicine was reviewed.